Literature DB >> 11462187

Prospective assessment of the etiology of acute febrile illness after a tick bite in Slovenia.

S Lotric-Furlan1, M Petrovec, T Avsic-Zupanc, W L Nicholson, J W Sumner, J E Childs, F Strle.   

Abstract

A prospective study established the etiology of febrile illnesses in residents of Slovenia that occurred within 6 weeks after a tick bite. A combination of laboratory and clinical criteria identified 64 (49.2%) of 130 patients as having confirmed, probable, or possible cases of tickborne disease during 1995 and 1996. Of the 130 patients, 36 (27.7%) had laboratory evidence of tickborne encephalitis, all of whom had clinically confirmed disease. Evidence of infection with Borrelia burgdorferi sensu lato was identified in 26 patients; 10 (7.7%) had confirmed Lyme borreliosis. Of 22 patients with evidence of Ehrlichia phagocytophila infection, 4 (3.1%) had confirmed ehrlichiosis. Infection by multiple organisms was found in 19 (14.6%) of 130 patients. Patients with meningeal involvement (43 [72.3%] of 59) were more likely to have confirmed tickborne disease than were patients with illness of undefined localization (18 [26.5%] of 68; P<.0001). Tickborne viral and bacterial infections are an important cause of febrile illness in Slovenia.

Entities:  

Mesh:

Year:  2001        PMID: 11462187     DOI: 10.1086/322586

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

Review 1.  Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences.

Authors:  Maria A Diuk-Wasser; Edouard Vannier; Peter J Krause
Journal:  Trends Parasitol       Date:  2015-11-21

Review 2.  Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management.

Authors:  Petra Bogovic; Franc Strle
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

3.  Diplorickettsia massiliensis as a human pathogen.

Authors:  G Subramanian; O Mediannikov; E Angelakis; C Socolovschi; G Kaplanski; L Martzolff; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-22       Impact factor: 3.267

4.  Epidemiological survey of tick-borne encephalitis virus and Anaplasma phagocytophilum co-infections in patients from regions of the Czech Republic endemic for tick-borne diseases.

Authors:  Petr Zeman; Petr Pazdiora; Vaclav Chmelik; Jiri Januska; Karel Sedivy; Alberto A Guglielmone; Jorge A Iriarte; Zuzana Medkova
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

5.  Epidemiological, clinical and laboratory characteristics of patients with human granulocytic anaplasmosis in Slovenia.

Authors:  Stanka Lotric-Furlan; Tereza Rojko; Miroslav Petrovec; Tatjana Avsic-Zupanc; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 2.275

6.  Borrelia burgdorferi and Anaplasma phagocytophilum coinfection.

Authors:  Micha Loebermann; Volker Fingerle; Matthias Lademann; Carlos Fritzsche; Emil C Reisinger
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

7.  Antibiotic Use and Long-Term Outcome in Patients with Tick-Borne Encephalitis and Co-Infection with Borrelia Burgdorferi Sensu Lato in Central Europe. A Retrospective Cohort Study.

Authors:  Maša Velušček; Rok Blagus; Tjaša Cerar Kišek; Eva Ružić-Sabljić; Tatjana Avšič-Županc; Fajko F Bajrović; Daša Stupica
Journal:  J Clin Med       Date:  2019-10-20       Impact factor: 4.241

8.  Concomitant tickborne encephalitis and human granulocytic ehrlichiosis.

Authors:  Stanka Lotric-Furlan; Miroslav Petrovec; Tatjana Avsic-Zupanc; Franc Strle
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

9.  Are patients with erythema migrans who have leukopenia and/or thrombocytopenia coinfected with Anaplasma phagocytophilum or tick-borne encephalitis virus?

Authors:  Franc Strle; Petra Bogovič; Jože Cimperman; Vera Maraspin; Katarina Ogrinc; Tereza Rojko; Daša Stupica; Lara Lusa; Tatjana Avšič-Županc; Katja Strašek Smrdel; Mateja Jelovšek; Stanka Lotrič-Furlan
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.